abstract |
The present invention has the formula (I) :. Wherein, R 2, R 3 and X are as defined in the specification, New azaindrill pyridone and diazaindrill pyridone compounds, pharmaceutical compositions containing such compounds, and cancer, type 2 diabetes, inflammatory disease, autoimmune disease, neurodegenerative disease, cardiovascular disorders and viral infections. Provided are methods of using such compounds in the treatment of diseases including. [Selection diagram] None |